As per this study the Global Atrial Fibrillation Market was valued USD 23.4 BN (by revenue) in 2022 and is anticipated to reach USD 54.32 BN by 2030 with a CAGR of 11.1%.
Atrial fibrillation (AFib or AF) is a common medical condition with abnormal, irregular and rapid heartbeat that results in poor blood flow. This condition often occurs when the electrical impulse fire off from varied places of atria in disorganized manner. Atrial fibrillation may lead to heart stroke, blood clots, and related complications. Various surgical and non-surgical procedures are used to treat atrial fibrillation.
Market Dynamics
Growing incidence of chronic heart diseases especially in geriatric population is driving the market growth. Obesity, high blood pressure, diabetes, excessive drinking and smoking and other lifestyle related problems are also accelerating the market growth. Ongoing advances for development of more effective, minimally invasive conditions are further boosting the growth of this market. However, high cost of treatment and lack of trained medical professionals may impact the market growth negatively.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of atrial fibrillation.
Market Segmentation
The broad atrial fibrillation market has been sub-grouped into type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Treatment Type
- Pharmacological Treatment (Anti-arrhythmic Drugs, Anticoagulant Drugs)
- Non-Pharmacological Treatment (Catheter Ablation (Radiofrequency, HIFU, Cryoablation, Microwave, Laser), Maze Surgery, Electric Cardioversion)
By End-Use
- Hospitals
- Specialty Clinics
- Others
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for atrial fibrillation in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Atrial Fibrillation Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Atrial Fibrillation market include AtriCure Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, Cardio Focus Inc., Sanofi Aventis, Biosense Webster Inc., Endoscopic Technologies Inc., Abbott (St. Jude Medical Inc.), Johnsons & Johnson. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.